Compare Cenovus Energy Inc (CVE) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cenovus Energy Inc vs Neurocrine Biosciences Inc — how do they compare? Cenovus Energy Inc trades at $29.83 (market cap $55.00B), while Neurocrine Biosciences Inc trades at $157.76 (market cap $16.46B). The key difference: Cenovus Energy Inc is far larger — about 3.3× Neurocrine Biosciences Inc's market cap, and Cenovus Energy Inc pays a 2.09% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| CVE | NBIX | |
|---|---|---|
Market Cap | $55.00B | $16.46B |
Sector | Energy | Health |
52-Week High | $31.80 | $185.50 |
52-Week Low | $14.83 | $123.10 |
Enterprise Value | $61.08B | $16.48B |
Dividend Yield | 2.09% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
